Newsbenzinga
Usana Health Sciences Lowers FY2026 Adj EPS Guidance from $0.76 to $0.55 vs $0.76 Est; Lowers FY2026 Sales Guidance from $910.000M to $900.000M vs $908.995M Est
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…


Comments —
Loading comments…